HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masayuki Kaneko Selected Research

N- (1- ((6- fluoro- 2- naphthyl)methyl)pyrrolidin- 3- yl)- 2- (1- ((6- methylpyridazin- 3- yl)carbonyl)piperidin- 4- ylidene)acetamide

6/2007A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masayuki Kaneko Research Topics

Disease

8Neoplasms (Cancer)
05/2020 - 03/2008
7Alzheimer Disease (Alzheimer's Disease)
05/2020 - 01/2010
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 05/2008
4Type 2 Diabetes Mellitus (MODY)
05/2019 - 07/2017
4Parkinsonian Disorders (Parkinsonism)
01/2012 - 06/2006
4Inflammation (Inflammations)
06/2007 - 10/2004
3Carcinoma (Carcinomatosis)
01/2022 - 09/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2015
3Neuroblastoma
01/2018 - 10/2004
3Parkinson Disease (Parkinson's Disease)
01/2016 - 01/2012
3Hypoxia (Hypoxemia)
11/2015 - 10/2004
3Asthma (Bronchial Asthma)
06/2007 - 01/2006
2Breast Neoplasms (Breast Cancer)
11/2021 - 07/2007
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2020 - 12/2019
2Necrosis
12/2019 - 03/2008
2Mucopolysaccharidosis II (Hunter Syndrome)
01/2019 - 01/2018
2Body Weight (Weight, Body)
03/2017 - 07/2015
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2017 - 04/2010
2Inborn Urea Cycle Disorders
01/2012 - 10/2004
2Atopic Dermatitis (Atopic Eczema)
06/2007 - 01/2006
2Leukemia
09/2005 - 10/2002
2Ischemia
11/2004 - 10/2004
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Chronic Renal Insufficiency
05/2020
1Colorectal Neoplasms (Colorectal Cancer)
05/2020
1Osteoporosis
01/2020
1Crohn Disease (Crohn's Disease)
12/2019
1Colitis
12/2019
1Ulcerative Colitis
12/2019
1Wounds and Injuries (Trauma)
02/2019
1Bone Fractures (Bone Fracture)
02/2019
1Congenital Abnormalities (Deformity)
01/2019
1Intellectual Disability (Idiocy)
01/2019
1Mucopolysaccharidoses
01/2019
1Drug-Related Side Effects and Adverse Reactions
12/2018
1Schizophrenia (Dementia Praecox)
08/2018
1Heart Failure
07/2017
1Diabetes Mellitus
03/2017
1Prostatic Neoplasms (Prostate Cancer)
11/2016
1Autism Spectrum Disorder
01/2016

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
11/2016 - 10/2004
7Pharmaceutical PreparationsIBA
11/2020 - 06/2007
6UbiquitinIBA
12/2019 - 05/2009
5Ligases (Synthetase)IBA
12/2019 - 01/2012
5Endothelin Receptors (Endothelin Receptor)IBA
01/2016 - 06/2006
4Amyloid (Amyloid Fibrils)IBA
01/2016 - 03/2010
44-phenylbutylamineIBA
01/2012 - 10/2004
3CaspasesIBA
12/2019 - 09/2005
34-phenylbutyric acid (Buphenyl)FDA Link
02/2015 - 10/2004
3Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
05/2009 - 12/2006
3CCR3 ReceptorsIBA
06/2007 - 01/2006
2PlatinumIBA
01/2022 - 07/2015
2Biomarkers (Surrogate Marker)IBA
01/2021 - 05/2020
2Iduronic Acid (Iduronate)IBA
01/2019 - 01/2018
2LigandsIBA
01/2015 - 04/2006
2Fatty Acids (Saturated Fatty Acids)IBA
01/2012 - 10/2004
2beraprostIBA
04/2010 - 09/2006
2Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2010 - 09/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 10/2004
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1Hormones (Hormone)IBA
11/2021
1NF-kappa B (NF-kB)IBA
05/2020
1Biological ProductsIBA
05/2020
1TOR Serine-Threonine KinasesIBA
05/2020
1Peptides (Polypeptides)IBA
01/2020
1Sulfonic AcidsIBA
12/2019
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2019
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
12/2019
1sym-trinitrobenzeneIBA
12/2019
1Investigational DrugsIBA
09/2019
1empagliflozinIBA
05/2019
1semaglutideIBA
05/2019
1omega-Chloroacetophenone (Mace)IBA
05/2019
1LiraglutideFDA Link
05/2019
1Sodium-Glucose Transporter 2 InhibitorsIBA
02/2019
1CanagliflozinIBA
02/2019
1Sodium-Glucose Transport ProteinsIBA
02/2019
1CalnexinIBA
01/2019
1Dermatan SulfateIBA
01/2019
1GlycosaminoglycansIBA
01/2019
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2019
1Antipsychotic Agents (Antipsychotics)IBA
08/2018
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018
1alogliptinIBA
07/2017
1saxagliptinFDA Link
07/2017
1Dipeptidyl-Peptidase IV InhibitorsIBA
07/2017
1Sitagliptin Phosphate (Januvia)FDA Link
07/2017
1Glucose (Dextrose)FDA LinkGeneric
03/2017
1AndrogensIBA
11/2016
1Androgen Receptors (Androgen Receptor)IBA
11/2016
1NeuroliginsIBA
01/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015
1LuciferasesIBA
11/2015
1Carboplatin (JM8)FDA LinkGeneric
07/2015

Therapy/Procedure

5Therapeutics
11/2021 - 11/2016
4Drug Therapy (Chemotherapy)
07/2015 - 03/2008
1Complementary Therapies (Alternative Medicine)
11/2021
1Surgical Amputation (Amputations)
02/2019